Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Phreesia (GB:0A23)
LSE:0A23
Holding GB:0A23?
Track your performance easily
0A23 Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$14.62 - $28.74
Previous Close$21.04
Volume5.42K
Average Volume (3M)436.00
Market Cap
$1.21B
Enterprise Value$1.15B
Total Cash (Recent Filing)$81.80M
Total Debt (Recent Filing)$16.52M
Price to Earnings (P/E)―
Beta0.58
Next Earnings
Dec 09, 2024EPS Estimate
-$0.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding57,773,275
10 Day Avg. Volume804
30 Day Avg. Volume436
Standard Deviation0.17
R-Squared0.01
Alpha0.00722
Financial Highlights & Ratios
Price to Book (P/B)4.22
Price to Sales (P/S)3.14
Price to Cash Flow (P/CF)27.70
P/FCF Ratio83.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.94
Enterprise Value/Gross Profit4.93
Enterprise Value/Ebitda-17.00
Forecast
1Y Price Target
$29.78Price Target Upside41.54% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
Phreesia News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceTotal revenue increased 19% YoY, driven by strong performance across different segments.
Growth PotentialManagement shared that average deal sizes in the pipeline are up ~20% YoY, indicating future growth potential.
Profitability And StrategySustained EBITDA upside is validating Phreesia’s strategy to focus on higher ROI engagements.
Bears Say
Growth ProfilePhreesia trades at a CY25E EV/revenue multiple of 2.7x, which is at a discount to the peer group median multiple, justified by uncertainty surrounding the growth profile of the business beyond FY25.
Market ExpectationsWhile there is an upward bias to 2Q revenue and adj-EBITDA, a corresponding guidance raise is not expected, which could be viewed unfavorably by the market.
Operational PerformanceThe company expects to add roughly 100 AHSCs in 2Q, marking the lowest number of AHSC adds sequentially since 2QFY'22.
---
Options Prices
Currently, No data available
---
Ownership Overview
5.97% Insiders
38.93% Mutual Funds
6.41% Other Institutional Investors
36.18% Public Companies and
Individual Investors
0A23 FAQ
What was Phreesia’s price range in the past 12 months?
Phreesia lowest share price was $14.62 and its highest was $28.74 in the past 12 months.
What is Phreesia’s market cap?
Currently, no data Available
When is Phreesia’s upcoming earnings report date?
Phreesia’s upcoming earnings report date is Dec 09, 2024 which is in 30 days.
How were Phreesia’s earnings last quarter?
Phreesia released its earnings results on Sep 04, 2024. The company reported -$0.31 earnings per share for the quarter, beating the consensus estimate of -$0.354 by $0.044.
Is Phreesia overvalued?
According to Wall Street analysts Phreesia’s price is currently Undervalued.
Does Phreesia pay dividends?
Phreesia does not currently pay dividends.
What is Phreesia’s EPS estimate?
Phreesia’s EPS estimate is -$0.27.
How many shares outstanding does Phreesia have?
Phreesia has 57,773,273 shares outstanding.
What happened to Phreesia’s price movement after its last earnings report?
Phreesia reported an EPS of -$0.31 in its last earnings report, beating expectations of -$0.354. Following the earnings report the stock price went down -0.787%.
Which hedge fund is a major shareholder of Phreesia?
Among the largest hedge funds holding Phreesia’s share is Deerfield Management Company, LP. It holds Phreesia’s shares valued at 4M.
---
Phreesia Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$29.78 (41.54% Upside)
$29.78 (41.54% Upside)
Blogger Sentiment
Bullish
GB:0A23 Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Sold Shares
Worth $1.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
31.92%
12-Months-Change
Fundamentals
Return on Equity
-40.26%
Trailing 12-Months
Asset Growth
6.40%
Trailing 12-Months
Company Description
Phreesia
Phreesia, Inc. provides patient check-in solutions for medical practices. It provides solutions that transform the healthcare experience by engaging patients in their care and enabling healthcare provider organizations to optimize operational efficiency, improve profitability and enhance clinical care. Through the SaaS-based Phreesia Platform the company offers healthcare provider organizations a robust suite of solutions to manage the patient intake process and a payments solution for secure processing of patient payments. Its platform also provides life sciences companies with an engagement channel for targeted and direct communication with patients. Phreesia was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in New York, NY.
---
0A23 Company Deck
---
0A23 Earnings Call
Q2 2024
0:00 / 0:00
---
0A23 Revenue Breakdown
45.91% Subscription and related services
27.90% Payment processing fees
26.19% Network solutions
---
0A23 Stock 12 Month Forecast
Average Price Target
$29.78
▲(41.54% Upside)
Technical Analysis
Best Analysts Covering 0A23
1 Year
1 Year Success Rate
4/10 ratings generated profit
1 Year Average Return
+2.11%
reiterated a buy rating 2 months ago
Copying Sean Wieland's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of +2.11% per trade.
---